RENAL TRANSPLANTATION AND A POSITIVE SEROLOGICAL CROSS-MATCH

P. J. Morris; D. O. Oliver; K. Williams; A. Ting; M. Bishop; M. S. Dunnill

doi:10.1016/S0140-6736(77)91322-8

RENAL TRANSPLANTATION AND A POSITIVE SEROLOGICAL CROSS-MATCH

P. J. Morris, D. O. Oliver, K. Williams, A. Ting, M. Bishop, M. S. Dunnill

Research output: Contribution to journal › Article › peer-review

44 Citations (Scopus)

Abstract

A renal transplant involving a recipient with a positive serological cross-match against donor lymphocytes generally results in hyperacute rejection of the graft. 13 cadaveric renal transplants were performed in recipients with a known positive serological cross-match against donor B lymphocytes. 12 of these serological cross-matches were positive against donor blood, node, or spleen lymphocytes, but the reactivity was directed against donor B lymphocytes only. 3 transplants failed, 2 because of rejection and 1 because of renal-artery thrombosis. 10 transplants are functioning, 6 to 42 weeks after the operation. Of these 10 successful grafts, 3 had no acute rejection episodes, while 7 had an early acute rejection episode which responded to treatment. Histologically, the grafts showed a cellular rejection, similar to that in enhanced renal allografts in the rat. It is possible to transplant a kidney in a high-risk patient with a positive B lymphocyte cross-match with a low risk of failure. In addition active enhancement of the graft might sometimes occur.

Original language	English
Pages (from-to)	1288-1291
Number of pages	4
Journal	The Lancet
Volume	309
Issue number	8025
DOIs	https://doi.org/10.1016/S0140-6736(77)91322-8
Publication status	Published - 18 Jun 1977
Externally published	Yes

Access to Document

10.1016/S0140-6736(77)91322-8Licence: In Copyright

Cite this

@article{c4db05a6b0a74d76a5c21e81e0e5dd26,

title = "RENAL TRANSPLANTATION AND A POSITIVE SEROLOGICAL CROSS-MATCH",

abstract = "A renal transplant involving a recipient with a positive serological cross-match against donor lymphocytes generally results in hyperacute rejection of the graft. 13 cadaveric renal transplants were performed in recipients with a known positive serological cross-match against donor B lymphocytes. 12 of these serological cross-matches were positive against donor blood, node, or spleen lymphocytes, but the reactivity was directed against donor B lymphocytes only. 3 transplants failed, 2 because of rejection and 1 because of renal-artery thrombosis. 10 transplants are functioning, 6 to 42 weeks after the operation. Of these 10 successful grafts, 3 had no acute rejection episodes, while 7 had an early acute rejection episode which responded to treatment. Histologically, the grafts showed a cellular rejection, similar to that in enhanced renal allografts in the rat. It is possible to transplant a kidney in a high-risk patient with a positive B lymphocyte cross-match with a low risk of failure. In addition active enhancement of the graft might sometimes occur.",

author = "Morris, {P. J.} and Oliver, {D. O.} and K. Williams and A. Ting and M. Bishop and Dunnill, {M. S.}",

year = "1977",

month = jun,

day = "18",

doi = "10.1016/S0140-6736(77)91322-8",

language = "English",

volume = "309",

pages = "1288--1291",

journal = "Lancet",

issn = "0140-6736",

publisher = "Lancet",

number = "8025",

}

TY - JOUR

T1 - RENAL TRANSPLANTATION AND A POSITIVE SEROLOGICAL CROSS-MATCH

AU - Morris, P. J.

AU - Oliver, D. O.

AU - Williams, K.

AU - Ting, A.

AU - Bishop, M.

AU - Dunnill, M. S.

PY - 1977/6/18

Y1 - 1977/6/18

N2 - A renal transplant involving a recipient with a positive serological cross-match against donor lymphocytes generally results in hyperacute rejection of the graft. 13 cadaveric renal transplants were performed in recipients with a known positive serological cross-match against donor B lymphocytes. 12 of these serological cross-matches were positive against donor blood, node, or spleen lymphocytes, but the reactivity was directed against donor B lymphocytes only. 3 transplants failed, 2 because of rejection and 1 because of renal-artery thrombosis. 10 transplants are functioning, 6 to 42 weeks after the operation. Of these 10 successful grafts, 3 had no acute rejection episodes, while 7 had an early acute rejection episode which responded to treatment. Histologically, the grafts showed a cellular rejection, similar to that in enhanced renal allografts in the rat. It is possible to transplant a kidney in a high-risk patient with a positive B lymphocyte cross-match with a low risk of failure. In addition active enhancement of the graft might sometimes occur.

AB - A renal transplant involving a recipient with a positive serological cross-match against donor lymphocytes generally results in hyperacute rejection of the graft. 13 cadaveric renal transplants were performed in recipients with a known positive serological cross-match against donor B lymphocytes. 12 of these serological cross-matches were positive against donor blood, node, or spleen lymphocytes, but the reactivity was directed against donor B lymphocytes only. 3 transplants failed, 2 because of rejection and 1 because of renal-artery thrombosis. 10 transplants are functioning, 6 to 42 weeks after the operation. Of these 10 successful grafts, 3 had no acute rejection episodes, while 7 had an early acute rejection episode which responded to treatment. Histologically, the grafts showed a cellular rejection, similar to that in enhanced renal allografts in the rat. It is possible to transplant a kidney in a high-risk patient with a positive B lymphocyte cross-match with a low risk of failure. In addition active enhancement of the graft might sometimes occur.

UR - http://www.scopus.com/inward/record.url?scp=0017414421&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(77)91322-8

DO - 10.1016/S0140-6736(77)91322-8

M3 - Article

C2 - 68386

AN - SCOPUS:0017414421

SN - 0140-6736

VL - 309

SP - 1288

EP - 1291

JO - Lancet

JF - Lancet

IS - 8025

ER -

RENAL TRANSPLANTATION AND A POSITIVE SEROLOGICAL CROSS-MATCH

Abstract

Access to Document

Other files and links

Fingerprint

Cite this